Benzinga | Jan 14, 2022 09:07AM EST

Morgan Stanley Maintains Equal-Weight on Colfax, Lowers Price Target to $51

Morgan Stanley analyst Joshua Pokrzywinski maintains Colfax (NYSE:CFX) with a Equal-Weight and lowers the price target from $56 to $51.